Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Fleck

Showing results (31-40 of 380) with videos related to

Pageof 38
Sort By:
Herz|December 1, 1982
[Effects of antianginal agents on myocardial blood flow]W Rudolph, E Fleck, J Dirschinger
Der Internist|December 20, 2005
[Cardiovascular MRT--replacement of diagnostic invasive coronary angiography?]S Kelle, E Nagel, E Fleck
Pediatrics in Review|November 3, 2017
Hand and Foot Color Change: Diagnosis and ManagementDustin E Fleck, Mark F Hoeltzel
Herz|June 1, 1979
[Hemodynamic actions of molsidomin in coronary artery disease. Effects on regional myocardial blood flow, segmental ventricular wall motion, ejection phase parameters, ventricular volumes, systemic and pulmonary artery pressures and cardiac output (author's transl)]E Fleck, J Dirschinger, W Rudolph
Current Opinion in Radiology|August 1, 1991
Coronary angiography and interventional cardiologyE Fleck, W Maier-Rudolf, H Oswald
British Heart Journal|May 1, 1983
Effect of postextrasystolic potentiation on amplitude and timing of regional left ventricular wall motion in ischaemic heart diseaseD G Gibson, E Fleck, W Rudolph
European Heart Journal|December 1, 1995
Effects of angiotensin receptor antagonists in heart failure: clinical and experimental aspectsV Regitz-Zagrosek, M Neuss, E Fleck
Basic Research in Cardiology|December 2, 1998
Myocardial angiotensin receptors in human heartsV Regitz-Zagrosek, J Fielitz, E Fleck
The American Journal of Cardiology|March 15, 1990
Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular heart diseasesV Regitz, A L Shug, E Fleck
Herz|August 19, 2000
Cardiovascular magnetic resonance: myocardial perfusionE Nagel, N al-Saadi, E Fleck
Pageof 38

Showing results (31-40 of 380) with videos related to

Sort By:
Pageof 38
Herz|December 1, 1982
[Effects of antianginal agents on myocardial blood flow]W Rudolph, E Fleck, J Dirschinger
Der Internist|December 20, 2005
[Cardiovascular MRT--replacement of diagnostic invasive coronary angiography?]S Kelle, E Nagel, E Fleck
Pediatrics in Review|November 3, 2017
Hand and Foot Color Change: Diagnosis and ManagementDustin E Fleck, Mark F Hoeltzel
Herz|June 1, 1979
[Hemodynamic actions of molsidomin in coronary artery disease. Effects on regional myocardial blood flow, segmental ventricular wall motion, ejection phase parameters, ventricular volumes, systemic and pulmonary artery pressures and cardiac output (author's transl)]E Fleck, J Dirschinger, W Rudolph
Current Opinion in Radiology|August 1, 1991
Coronary angiography and interventional cardiologyE Fleck, W Maier-Rudolf, H Oswald
British Heart Journal|May 1, 1983
Effect of postextrasystolic potentiation on amplitude and timing of regional left ventricular wall motion in ischaemic heart diseaseD G Gibson, E Fleck, W Rudolph
European Heart Journal|December 1, 1995
Effects of angiotensin receptor antagonists in heart failure: clinical and experimental aspectsV Regitz-Zagrosek, M Neuss, E Fleck
Basic Research in Cardiology|December 2, 1998
Myocardial angiotensin receptors in human heartsV Regitz-Zagrosek, J Fielitz, E Fleck
The American Journal of Cardiology|March 15, 1990
Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular heart diseasesV Regitz, A L Shug, E Fleck
Herz|August 19, 2000
Cardiovascular magnetic resonance: myocardial perfusionE Nagel, N al-Saadi, E Fleck
Pageof 38